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ABSTRACT
Z-DNA binding protein 1 (ZBP1) belongs to a family
of proteins that contain the Za domain, which binds
specifically to left-handed Z-DNA and Z-RNA. Like
all vertebrate proteins in the Za family, it contains
two Za-like domains and is highly inducible by
immunostimulation. Using circular dichroism spec-
troscopy and electrophoretic mobility shift assays
we show that both Za domains can bind Z-DNA
independently and that substrate binding is greatly
enhanced when both domains are linked. Full length
ZBP1 and a prominent splice variant lacking the
first Za domain (DZa) showed strikingly different
subcellular localizations. While the full length pro-
tein showed a finely punctate cytoplasmatic distri-
bution, ZBP1DZa accumulated in large cytoplasmic
granules. Mutation of residues important for Z-DNA
binding in the first Za domain resulted in a distribu-
tion comparable to that of ZBP1DZa. The ZBP1DZa
granules are distinct from stress granules (SGs) and
processing bodies but dynamically interacted with
these. Polysome stabilization led to the disassembly
of ZBP1DZa granules, indicating that mRNA are
integral components. Heat shock and arsenite
exposure had opposing effects on ZBP1 isoforms:
while ZBP1DZa granules disassembled, full length
ZBP1 accumulated in SGs. Our data link ZBP1 to
mRNA sorting and metabolism and indicate distinct
roles for ZBP1 isoforms.
INTRODUCTION
The left-handed Z-conformation is an alternative, higher
energy form that can be adopted by double-stranded DNA
and RNA, preferentially by sequences containing alternating
purine–pyrimidine nucleotides (1–3). In Z-DNA and Z-RNA
the (desoxy)ribo-phophate backbone forms a left-handed,
zigzag helix where the glycosidic bonds between base and
sugar alternate between the syn- and anti-conformation and
the purines are tilted to the outside. In contrast, in B-DNA
and A-RNA the backbone forms a smooth right-handed
helix and all nucleotides are in the anti-conformation facing
towards the inside of the helix. At the boundary between
B-DNA and Z-DNA, a B-Z junction is formed in which
a base pair is broken and the bases are extruded on each
side (4).
Under physiological conditions, Z-DNA formation is
enhanced by negative supercoiling, which is generated by
moving RNA-polymerases during transcription (5). Z-DNA
can either enhance or repress promoter activity, probably
by modulating the local architecture of transcriptional control
regions and nucleosome positioning (6–9).
Additionally, Z-DNA and Z-RNA can be bound by Z-DNA
binding proteins (ZBPs). These proteins contain one or two
copies of a domain, Za, which can speciﬁcally stabilize
and induce Z-DNA and Z-RNA. Co-crystallization of Za
domains has revealed that Z-DNA is recognized in a
conformation-speciﬁc manner (10–12). Identiﬁed members
of this family in vertebrates are Z-DNA binding protein
1 (ZBP1/DLM-1) (11), the RNA editing enzyme ADAR1
(13,14) and protein kinase containing Z-DNA binding
domains (PKZ) (15,16). They contain two structurally related
Za domains, which are tandemly arranged at the amino-
terminus of the proteins and are separated by a linker of vari-
able size (15–91 amino acids) (15). Within the context of a
protein, the N-terminal of these domains is referred to
as Za, while the C-terminal domain is referred to as Zb.
Vertebrate ZBPs are induced by immunostimulation and are
thought to be involved in host defense mechanisms
(15,17–19).
To overcome the host response, poxviruses possess a viru-
lence factor, called E3L in vaccinia virus, which contains a
single N-terminal Za domain and a double-stranded RNA
binding domain in the C-terminus (13). There is evidence
to suggest that the postulated immune function of ZBPs is
dependent on their ability to bind Z-DNA/Z-RNA. Single
point mutations in the Za-domain of E3L that prevented
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was fully restored by substitution of the Za domain of E3L
with that of ADAR1 or ZBP1, although these Za domains
share only  25% sequence identity (20). The Za domain
of E3L has been proposed to compete with cellular ZBPs
for the binding of target sequences, resulting in inhibition
of activation or loss of proper localization of ZBPs (21,22).
ZBP1 was identiﬁed as a gene that was up-regulated in
mouse tumor stromal cells and it was speculated that it
plays a role in the host response against tumors (18).
Human ZBP1 is most prominently expressed in lymphatic
tissues indicating a role in the modulation of immune func-
tions (22). The ZBP1 gene contains 10 exons and encodes
a protein with a predicted molecular mass of 46 kDa, con-
taining two N-terminal Za domains and a C-terminus of
unknown function (22). As a result of alternative splicing
and the use of alternative transcriptional start and stop sites,
ZBP1 mRNA are very heterogeneous. Exon 2, coding for the
ﬁrst Za domain, is spliced out in  50% of ZBP1 mRNA (22).
A similar distribution was observed by analyzing expressed
sequence tags (ESTs) of ZBP1 (S. Rothenburg, unpublished
data).
In this study, we discovered an association between ZBP1
and stress granules (SGs) and processing bodies (PBs), which
are both cytoplasmic aggregates of RNA and proteins. SGs
and PBs are distinct granules that play important roles
in the regulation of mRNA metabolism and degradation
(23–25). SGs are formed in response to environmental stress
and consist of stalled 48S translational preinitiation com-
plexes, translation initiation factors and many RNA bind-
ing proteins such as 50–30 exonuclease 1 XRN1, cytotoxic
granule-associated RNA binding protein TIA1 and RasGAP-
associated endoribonuclease G3BP (25–27). Although SGs
and PBs are distinct structures, they share several components
for mRNA sorting and remodelling. Furthermore PBs but not
SGs contain components of the decapping enzyme complex
including DCP1a and the RNA-induced silencing complex
(25). According to the model of Anderson and Kedersha,
mRNA can be stored in SGs and can either be exported for
translational reinitiation after recovery from cell stress or
can be exported to PBs where mRNA can be degraded
(25,28). The formation of SGs but not PBs is partly mediated
by the phosphorylation of eIF2a following the activation of
eIF2a kinases such as double-stranded RNA-activated
protein kinase (PKR; activated by interferons and viral
RNA) or GCN2 (by amino acid deprivation) (25,29). SG
cannot form in the absence of eIF2a phosphorylation
(25,26,30).
Here we have characterized the binding of ZBP1 Za
domains to Z-DNA in vitro and show that both, the Za and
Zb domains, play roles in determining the subcellular local-
ization of ZBP1. Furthermore we show that full length
ZBP1 relocates from the cytoplasm to SGs but not to PBs
if cells are subjected to environmental stress. In contrast,
the isoform lacking Za is found in granules distinct form
SGs and PBs in unstressed cells. The ZBP1DZa granules dis-
assemble during stress. The identiﬁcation of full length ZBP1
as a previously unknown component of SGs and an observed
dynamic interaction of ZBP1DZa granules with SGs and PBs
link ZBP1 to RNA translation and sorting and indicate differ-
ent roles for ZBP1 isoforms.
MATERIALS AND METHODS
Plasmids
Human leukocyte cDNA was used as the template for PCR
using AmpliTaq Gold polymerase (PE Biosystems) with pri-
mers hDLM1f (50-CCG ACT CCT TGC AGC TGC TGT
C-30) and hDLM6r (50-ACT CCC TGT CAT CTA CTC CTG
GCC-30) as described (22) and cloned into pCR2.1 (Invitro-
gen). After sequencing clones containing the complete open
reading frame (ZBP1 full), or having exon 2 spliced out
(ZBP1DZa), were chosen as templates for subsequent PCR
and cloning. PCRs were performed using vector primer
M13R (50-GGC AGG AAA CAG CTA TGA CC-30) and
hDLM Del2R XbaI (50-CTG CTC TAG ACC CAC GTG
AGG CTG TGC AC-30). Restriction sites in all primers are
underlined. PCR products were subsequently digested with
Kpn I and Xba I (New England Biolabs), gel-puriﬁed and
ligated into pcDNA3.1zeo (Invitrogen, Groningen, Nether-
lands). The complete open reading frames and cloning sites
of each construct reported in this manuscript were sequenced
using the dye terminator protocol (PE Applied Biosystems)
according to the manufacturer’s instructions. Sequence anal-
ysis was performed with Lasergene software (DNASTAR).
For native subcellular localization assays ZBP1 full,
ZBP1DZa, ZBP1e1-5 and ZBP1DZae1-5 were ampliﬁed by
PCR with hZBP1 1F EcoRI (50-AGG AAT TCG CCG
CCA CCA TGG CCC AGG CTC CTG C-30) and hZBP1
1R BamHI (50-CGG GAT CCC CAC CTC CCC ACC
AGC TCC-30) for ZBP1 full and ZBP1DZa or hZBP1 2R
BamHI (50-CGG GAT CCT CCC TGG AGA CTG TCT
GTC-30) for ZBPlel-5 and ZBP1DZae1-5. PCR products
were cloned into pCR2.1 using TA cloning kit (Invitrogen).
The correct plasmids were digested with BamHI and
EcoRI, for plasmids containing ZBP1 full and ZBP1DZa
under limited conditions for EcoRI because of an internal
EcoRI restriction site in exon 8 of hZBP1. The fragments
were puriﬁed and ligated into the multiple cloning site of
pEGFP-N1 (Clontech) using T4 DNA Ligase (New England
Biolabs). pZBP1full-GFP and pZBP1DZa-GFP were used as
templates for the construction of pZBP1DZb-GFP and
pZBP1DZaDZb-GFP, respectively, where exon 4 was pre-
cisely deleted: the templates were digested with BbsI,
which uniquely cuts within exon 4. Subsequently PCRs
were performed with forward primer hZBP1DZb MluF (50-
TCC AAC GCG TGG AAG ATT CTG GAA GAA GAG
CAA AG-30), which starts at the beginning of exon 5, and
reverse primer hZBP1DZb MluR (50-CTC TTT GAC GCG
TTG TTG GCT GAA CTG AGG GC-30), which starts at
the end of exon 3. PCR products were subsequently MluI
(New England Biolabs) digested, gel-puriﬁed and ligated.
TIA1-GFP and DCP1a-mRFP were kindly provided by
Nancy Kedersha (Boston, USA). G3BP-GFP was kindly pro-
vided by Jamal Tazi (Montpellier, France). The reading frame
of EGFP in pEGFP-N1 was replaced by monomeric red ﬂuo-
rescent protein (mRFP) that was ampliﬁed by mRFP1F AgeI
(50-TTG TAA CCG GTG GCC ACC ATG GCC TCC TCC
GAG-30) and mRFP1R NotI (50-TTA ATC GCG GCC GCT
ATT AGG CGC CGG TGG AGT GGC GGC-30) with indi-
cated enzymes, yielding pmRFP-N1. ZBP1 open reading
frames from hZBP1 full-GFP and ZBP1DZa-GFP were
excised with NheI and BamHI and ligated into pmRFP-N1
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speciﬁc mutations were generated by PCR mutagenesis
using KOD Hot start polymerase (Novagen) and primers con-
taining the desired mutation following the Quick Change pro-
tocol (Stratagene). Following PCR with 18 cycles the
products were digested with DpnI (New England Biolabs)
and transformed into ultracompetent XL-10 Escherichia
coli (Stratagene).
For two proximate amino acid substitutions in ZaZBP1 two
mutagenesis PCRs were performed consecutively. For single
mutations in ZBP1Za PCR with hZBP1 N46D F(50-CAA
GAG GGA GCT CGA CCA AGT CCT CTA CC-30) and
hZBP1 N46D R (50-GGT AGA GGA CTT GGT CGA GCT
CCC TCT TG-30) or hZBP1 Y50A F (50-GCT CAA CCA
AGT CCT CGC CCG AAT GAA AAA GGA GTT-30) and
hZBP1 Y50A R (50-CAA CTC CTT TTT CAT TCG GGC
GAG GAC TTG GTT GAG C-30) was performed, followed
by a second mutagenesis PCR for double mutation with
hZBP1 N46D Y50A F (50-CAA GAG GGA GCT CGA
CCA AGT CCT CGC CC-30) hZBP1 N46D Y50A R (50-
GGG CGA GGA CTT GGT CGA GCT CCC TCT TG-30).
The substitutions in ZbZBP1 were generated by mutagenesis
PCR with hZBP1 N141D Y145A F (50-ACA GCA AAA
GAT GTG GAC CGA GAC TTG GCC AGG ATG AAG
AGC AGG-30) and hZBP1 N141D Y145A R (50-GGG
CGA GGA CTT GGT CGA GCT CCC TCT TG-30) in one
step. For recombinant protein expression cDNA from
hZBP1 was PCR ampliﬁed and inserted into pET28a
(Novagen) with a cutting site for PreScission protease (GE
Healthcare) instead of Thrombin (kindly provided by Thomas
Schwartz, Cambridge, MA, USA). In detail ZaZBP1,Z bZBP1
and ZabZBP1 were ampliﬁed using primers with NheI and
BamHI restriction sites at their termini and cloned into the
multiple cloning site of the modiﬁed pET28a. For ZaZBP1
the ampliﬁed sequence comprises exons 1 and 2: hZBP1
P5F NheI (50-AAA GGA GCT AGC GCT CCT GCT GAC
CCG GGC AG-30) and hZBP1 P4R BamHI (50-CGG GAT
CCT TAT CAA GGG CTG GAC AAG GCC AGC TC-30).
The ZabZBP1 construct (comprising exons 1–4) was cloned
using hZBP1 P5F NheI as forward primer and hZBP1 P5R
BamHI (50-CGG GAT CCT TAT CAT GGG CGG TAA
ATC GTC CAT GC-30) as reverse primer. For the ZbZBP1
construct, comprising exons 1, 3 and 4, ZBP1DZa was
used as template for PCR ampliﬁcation with the same primers
as were used for the ZabZBP1 construct. ZabADAR1 was con-
structed essentially as described (31).
Generation and purification of anti-ZBP1 antibodies by
genetic immunization
A fragment of the ZBP1 cDNA (exons E1–E4 encoding
ZabZBP1) was ampliﬁed by PCR using primers harboring
suitable restriction enzyme sites (50-GAA AGA TCT GCT
CCT GCT GAC CCG GGC AG-30 and 50-CTT TCC AAG
CTT TTG GGC GGT AAA TCG TCC ATG C-30). The PCR
product was cloned into the pME18S mammalian expression
vector so that the ZBP1 coding region was fused downstream
of the coding region for the CD8 signal peptide followed by
a FLAG-tag and upstream of the ART4 GPI-signal sequence
(32). Transfection of the pME.CD8Fl_ ZBP1ZaZb_GPI
construct into HEK cells veriﬁed that the resulting ZabZBP1
protein was expressed as a FLAG-tagged-GPI-anchored
cell-surface protein. The pME.CD8Fl_ ZBP1ZaZb_GPI con-
struct was used for genetic immunization of rabbit CR5
essentially as described previously (33). Recombinant
ZabZBP1 was immobilized on Aminolink matrix (Pierce)
according to the manufacturer’s instructions. This matrix
was used for afﬁnity puriﬁcation of CR5 immune
serum, using 100 mM glycine, pH 2.7 for elution of bound
antibody.
Immunofluorescence analysis
Cells were ﬁxed for 10 min with 4% para-formaldehyde in
phosphate-buffered saline (PBS), permeabilized and blocked
(2% BSA, 3% goat serum, 0.5% Nonidet P-40 in PBS) and
incubated with afﬁnity-puriﬁed anti-hZBP1 antibody for
2 h. After washing three times with high-salt PBS (contain-
ing 650 mM NaCl to diminish unspeciﬁc binding) and
three times with PBS, cells were incubated with secondary
R-Phycoerythrin-(RPE) conjugated anti-rabbit F(ab’)2 frag-
ment (Dianova) for 2 h and subsequently washed three times
with PBS. In order to check the speciﬁcity of immunoreactiv-
ity of the puriﬁed rabbit serum, 10 mg/ml of recombinant
ZabZBP1 was added to cells concomitantly with the antibod-
ies. Nuclei were stained with Hoechst33342 in 1:4000 dilu-
tion, incubated for 20 min at 37 C and subsequently washed
twice with PBS. Occasionally, small dots in the cytoplasm
or outside cells were observed. These dots correspond to trans-
fected plasmid DNA/transfection agent complexes and were
never seen in non-transfected control cells. Fluorescence
microscopy was performed using Axiovert 200M (Zeiss)
with 20· (Plan-Apochromat 20·/0.75), 40· (EC Plan-
Neoﬂuar 40·/0.75 M27) or 63· oil objective (Plan-Neoﬂuar
63·/1.25 oil). Photos were taken with AxioCam MR (Zeiss)
and analyzed with Axiovision 4.4 SP2. For time-lapse experi-
ments photos were taken every 30 s over a 15 min time period
and animations were made with Axiovision 4.4 time-lapse
module.
Cell culture and transfection
HeLa cells were kindly provided by Joe Glavy (New York
City, USA), Hep2 cells were kindly provided by Matthias
Kalitzky (Hamburg, Germany). Cells were grown in
D-MEM supplemented with 10% fetal calf serum, 2 mM
L-glutamine, 100 mM non-essential amino acids, 1 mM
sodium pyruvate and 50 mg/ml Gentamicin at 37 Ci n5 %
CO2 atmosphere. For immunoﬂuorescence experiments tissue
cells were seeded 24 h prior to transfection onto 8-well
m-slides or m-dishes (Ibidi) with 180 mm thin bottoms for
short distance microscopy. Cells were transfected with the
indicated plasmids using polyethylenimine (jetPEI, Qbio-
gene) following manufacturer’s instructions. Plasmids for
double transfections were applied in a 1:1 ratio. In detail,
0.25 mg of each plasmid was used for each transfection in
a 250 ml volume. 8–12 h after transfection cells were visual-
ized by ﬂuorescence microscopy, or ﬁxed for subsequent
staining. To inhibit nuclear export, 5 mg/ml Leptomycin B
(LMB, Calbiochem) was added to HeLa cells 2 h after trans-
fection and retained for 8 h. LMB-treated transfectants were
compared to untreated transfectants.
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HeLa cells were transfected as described above and lysed
after 10 h with PBS containing 1% SDS. Total cell lysates
were analyzed by SDS–PAGE followed by blotting onto
PVDF membrane (Invitrogen). The membrane was blocked
with 5% milk powder in TBS and probed with anti-GFP-
Antibody (Roche).
Expression of recombinant protein
Proteins were overexpressed in E.coli BL21(DE3)
(Novagen). Bacteria were grown at 37 C in Luria Broth
Base with 30 mg/ml Kanamycin and 0.4% D-(+)Glucose
for catabolite repression and induced between 0.8 and
1.1 A600 nm U with 0.3 mM isopropyl-b-D-thiogalactopyra-
noside for 4 h. All subsequent steps were performed at
4 C. Cells were spun down at 10000 g for 10 min and
resuspended in BugBuster (Novagen) supplemented with
25 U/ml Benzonase-Nuclease (Novagen), 100 mM 4-(2-
aminoethyl)benzenesulphonyl ﬂuoride (MP Biomedicals)
and 5 mM b-mercaptoethanol (b-ME). The suspension was
rocked for 30 min and centrifuged at 13000 g for 10 min.
The supernatant was incubated with Ni-NTA His-bind resin
(Novagen) and washed three times with 12 ml Buffer A
[20 mM Tris–HCl (pH 8), 250 mM NaCl, 5 mM b-ME,
7 mM imidazole] and once with 10 ml Buffer B [20 mM
Tris–HCl (pH 8), 2 M NaCl, 5 mM b-ME] in a batch. The
resin was then transferred into a column and washed with
10 ml Buffer C [20 mM Tris–HCl (pH 8), 250 mM NaCl,
5m Mb-ME, 15 mM imidazole] and ﬁnally the His6-tagged
protein was eluted with 8 ml Buffer D [20 mM Tris–HCl (pH
8), 250 mM NaCl, 5 mM b-ME, 250 mM imidazole]. Frac-
tions were analyzed by SDS–PAGE followed by Coomassie
staining. Fractions with recombinant protein were dialyzed
against Buffer E [20 mM HEPES (7.4), 40 mM NaCl,
1 mM DTT] and 1 U PreScission protease (GE Healthcare)
per microgram of estimated recombinant protein was added
for >12 h in order to remove the N-terminal His6-tag. Recom-
binant proteins were further puriﬁed by cation-exchange
chromatography on a HiTrap SP FF column (GE Healthcare).
The yield was determined by UV spectrometry at 280 nm.
About 10–15 mg puriﬁed recombinant protein was obtained
from 1 liter of culture.
Circular dichroism measurements
Circular dichroism (CD) spectra were recorded at 24 Co na
Jasco J-810 CD spectrometer (Jasco) using a cuvette with
optical pathlength of 1 mm. Spectra were recorded in
1 nm-steps as the mean of three measurements with scanning
speed of 200 nm/min and were further analyzed with Sigma
Plot 9.0 software. The conformational change of the DNA
was measured between 220 and 320 nm, and protein spectra
were measured between 190 and 320 nm. The measurement
was carried out in 10 mM HEPES (7.4), 20 mM KF and
0.1 mM EDTA. When determining the effect of protein on
DNA conformation, although the CD signal below 240 nm
is dominated by the negative ellipticity of the proteins, no
baseline correction was applied because the proteins did not
show signiﬁcant CD signal >245 nm (data not shown).
DNA was obtained as ds(poly(dC–dG) 500) from GE Health-
care and concentration was determined by UV spectrometry
at 260 nm. Protein was added to the DNA and incubated
for 30 min at 24 C prior to recording.
Electrophoretic mobility shift assay
DNA binding was assayed by native TBE PAGE. (dC–dG)20
oligomers were annealed, FPLC-puriﬁed and 50 end-labeled
using polynucleotide kinase (New England Biolabs) and
[g-32P]ATP. A reaction mixture containing 10 mM Tris–
HCl (pH 7.8), 20 mM NaCl, 5 mM DTT, 5% glycerol,
100 mg/ml BSA, 600 ng/ml sheared salmon sperm DNA,
indicated concentration of recombinant protein and 0.1 pM
DNA-probe was incubated for 30 min at 24 C. The mixture
was separated on a 6% TBE–Polyacrylamide Gel using
0.5· TBE as running buffer at 10 V/cm. TBE Gels were blot-
ted onto positively charged nylon membranes (Hybond N+,
GE Healthcare) and exposed at  80 C to BioMax ﬁlms
(Kodak) with intensifying screen.
RESULTS
The presence of two Za domains enhances formation
of Z-DNA in vitro
In mammalian ADAR1, the two Za-like domains vary in
DNA binding activity in vitro;Z aADAR1 binds Z-DNA in
CD spectroscopy and electrophoretic mobility shift assays
(EMSA), while isolated ZbADAR1 has never been shown to
bind DNA, although the crystal structure of ZbADAR1 shows
that it is folded in a similar way to ZaADAR1 (34). However,
together with Za,Z b can enhance binding to Z-DNA (31).
One reason for the inability to bind the Z-form on its own
is the presence of isoleucine at position 335 instead of tyro-
sine (Figure 1A). The latter is conserved in most Za domains
and is important for hydrogen bonding with Z-DNA as shown
in the co-crystal structures of human ZaADAR1, mouse
ZaZBP1 and yaba-like virus ZaE3L (10–12). In addition to
the conserved tyrosine two further residues, an asparagine
and a tryptophan (marked by asterisks in Figure 1A), both
important for DNA contact, and critical residues that make
up the hydrophobic core are highly conserved in all identiﬁed
Za proteins (15) (Figure 1A). The Zb domain of mammalian
ZBP1 lacks the conserved proline adjacent to the b3 sheet
(Figure 1A). This residue is important for the shape of the
wing and makes van der Waal’s contact with the DNA.
Therefore it was not clear if ZbZBP1 without an accompany-
ing ZaZBP1 domain, as found in a prominent ZBP1 splice
variant, can actually bind the Z-conformation independently
and whether the presence of two tandemly arranged Za
domains modulates Z-binding.
In order to address the DNA binding characteristics of
the two Z-DNA binding domains of human ZBP1, they
were recombinantly expressed as His6-tagged proteins in
E.coli, either separately (ZaZBP1 or ZbZBP1) or in combina-
tion (ZabZBP1). Human ZabADAR1, which has been previ-
ously shown to bind Z-DNA, was used as control (31).
After Ni-NTA puriﬁcation and subsequent cleavage of the
His6-tag by digestion with PreScission protease, proteins
were further puriﬁed by FPLC (Figure 2). We used CD
spectroscopy to monitor the conformational change from
B- to Z-DNA as induced by the recombinant proteins. The
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Z-DNA form by CD due to an inversion of the spectrum
between 240 and 300 nm. Figure 3 shows the spectra of
poly(dC–dG) either in the absence or presence of different
Z-DNA binding domains.
At low salt concentration and in the absence of protein the
DNA adopted the B-conformation, resulting in a CD graph
characterized by negative ellipticity at 255 nm and positive
ellipticity at 290 nm (Figure 3A–E). Addition of increasing
amounts of ZBP domains resulted in inverted CD spectra,
similar to DNA at high salt concentration, characterized by
positive ellipticity at 255 nm and negative ellipticity at
290 nm. Both Za domains of human ZBP1 induced a confor-
mational change of double-stranded DNA (Figure 3A and B).
If both domains were tethered to one another (ZabZBP1)
Z-DNA was formed more efﬁciently (Figure 3C) as compared
to the single domains. The single Za domains reached satura-
tion earlier than ZabZBP1 (compare Figure 3A and B with
Figure 3C, respectively). ZabADAR1 showed a similar spec-
trum as previously described (Figure 3D) (31). When the
spectra are compared at the same molar ratio, ZabZBP1
showed the highest propensity to induce Z-DNA formation
(Figure 3A–D). Time dependent change of ellipticity at
255 nm wavelength in the CD spectra is shown in Figure 3F.
Addition of wildtype ZabZBP1 resulted in a biphasic increase
in ellipticity, showing a fast increment for 5 min followed
by a slower but progressive increase. Mutation of four
amino acids (N46D, Y50A, N141D and Y145A), which are
important for Z-DNA binding as deduced from the crystal
structures, yielded soluble protein, comparably folded to
the wildtype as observed in CD spectra between 190 and
240 nm (data not shown), but with no ability to induce
conformational change of DNA (Figure 3E and F). When
the conserved asparagines and tyrosines were substituted
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Figure 2. SDS–PAGE analysis of recombinant proteins used for CD-
spectrometry and EMSA. 500 nmol of each purified protein was subjected to
SDS–PAGE and visualized by Coomassie Brilliant blue staining: Lane M,
molecular mass marker; lane 1: ZabADAR1; lane 2: ZaZBP1; lane 3: ZbZBP1;
lane 4: ZabZBP1; lane 5: ZabZBP1N46D; lane 6: ZabZBP1Y50A; lane 7:
ZabZBP1N46D/Y50A; lane 8: ZabZBP1N141D/Y145A; lane 9: ZabZBP1
N46D/Y50A/N141D/Y145A.
Figure 1. Comparison of Za domains (A) and schematic representation of constructs used for transfections (B) and protein expression (C). Comparison of Za
domains of human (hs) and mouse (mm) ZBP1, human ADAR1, zebrafish (dr) PKZ, vaccinia virus (vv) E3L and yaba-like disease virus (yldv) E3L is shown (A).
The structures of the mouse (mm) ZaZBP1, human (hs) ZaADAR1, yaba-like disease virus (yldv) ZaE3L domains have been determined in complex with Z-DNA.
Residues that make contact with Z-DNA, or the analogous residues in other Za domains, are boxed in light blue. Asterisks mark the conserved asparagine and
tyrosine residues that have been mutated in this study in hsZBP1, as well as a conserved tryptophan. Residues that form the hydrophobic core are boxed in green.
Residues that are neither DNA contacting nor structural but match the consensus sequence are highlighted in yellow. Isoleucine 335 in ZbADAR1 is highlighted in
red. (B) The exon composition of the most prominent ZBP1 splice variants ZBP1full and ZBP1DZa as well as that of artificial constructs are shown. Exon 7 is
rarely found in mRNA. Exon 9 contains an alternative termination site (22). ZBP1full and ZBP1DZa have been expressed as un-tagged or GFP tagged proteins in
HeLa cells. ZBP1DZb, ZBP1DZaDZb, ZBP1E1-5 and ZBP1E1-5DZa were expressed as GFP-tagged proteins. Schematic representation of the exon composition
of constructs expressed from pET28a (p28) vectors in E.coli are shown in (C).
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intact, comparably folded, soluble proteins were
produced as observed in CD spectra. However, addition of
DNA to the mutated proteins resulted in immediate
precipitation.
EMSA were previously used to analyze binding of Za
domains of ADAR1 to Z-DNA (31). The binding of Za pro-
teins to the probe was tested in the presence of a 20000-fold
excess of salmon sperm DNA as competitor (Figure 4A and
B). Double-stranded (dC–dG)20 was used as a probe because
Za proteins have been shown to convert it from the B- to the
Z-conformation. The proteins were tested at different concen-
trations and adjusted to the number of Za domains, i.e. Zab
was used at half the molar concentration as Za and Zb.
ZabZBP1 (Figure 4A, lanes 2–4) shifted the probe at lower
concentrations than Za (Figure 4A, lanes 5–7) and Zb
alone (Figure 4A, lanes 8–10). When Za and Zb were
mixed together a comparable bandshift was observed as
seen when only Za or Zb were used (Figure 4A, lanes
11 and 12). A radiolabeled probe with arbitrary sequence
of comparable length, without the propensity to adopt
Z-conformation was used as control, did not form complexes
with Za proteins (data not shown).
Amino acid residues that are conserved in ZBPs and
have been shown to be important for Z-DNA binding were
mutated in Za or Zb or in both domains of ZabZBP1. Mutants
N46D, Y50A, N46D/Y50A, N141D/Y145A and N46D/
Y50A/N141D/Y145A were analyzed for Z-DNA binding at
equimolar concentrations. All mutations drastically
reduced binding to Z-DNA as compared to the wildtype
(Figure 4B). Even single amino acid substitutions abolished
shifting of the probe. ZabADAR1 was used as positive control
(Figure 4B, lane 2).
Gene products of ZBP1 splice variants that either
contain or lack ZaZBP1 show strikingly different
subcellular localizations
In order to analyze the subcellular localization of ZBP1,
human HeLa cells, which do not express endogenous
ZBP1, were transiently transfected for 8–12 h with full length
human ZBP1 and stained with anti-ZBP1 antibodies gener-
ated by genetic immunization. Nuclei were stained with
Hoechst33342 (blue, middle panel). Approximately 30% of
cells showed strong, mainly cytoplasmic staining for ZBP1
(Figure 5A). Untransfected cells showed no staining. Staining
of ZBP1 transfected cells could be completely blocked by the
addition of recombinant ZabZBP1 demonstrating speciﬁcity of
the antibodies (Figure 5B).
The most prominent alternative splice variant of ZBP1
(DZa) encodes a protein that differs from full length ZBP1
solely by the absence of ZaZBP1. In order to determine
Figure 3. Conformational change of poly(dC–dG) in the presence of Za proteins in CD-spectrometry. The CD spectra show the titrations of ZaZBP1 (A), ZbZBP1
(B), ZabZBP1 (C) and ZabADAR1 (D). The curves show DNA spectra in the absence (control, B-DNA) and in the presence of protein at protein/basepair molar
ratio as labeled. Spectra were measured after 30 min of incubation at 24 C. (E) The CD spectra of wildtype (wt) ZabZBP1 and quadruple mutant (ZabZBP1mut)
carrying the four amino acid substitutions N46D, Y50A, N141D and Y145A are shown in relation to the control, where no protein was added. (F) Time
dependent change of ellipticity at 255 nm wavelength over 30 min ZabZBP1 and ZabZBP1mut are shown. Spectra are expressed in absolute values of ellipticity in
millidegrees (mdeg).
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localization of ZBP1, we compared the staining of HeLa
cells transfected with constructs containing or lacking
Za. The staining pattern of ZBP1 transfected HeLa cells
is shown in Figure 5C–H. The majority ( 80%) of cells
transfected with full length ZBP1 showed a ﬁnely punctate
cytoplasmic staining pattern as shown in Figure 5C and D.
The remainder of transfected cells showed small cytoplasmic
granules and weak nuclear staining in addition to the punctate
staining (Figure 5E). In contrast, cells transfected with
ZBP1DZa showed a strikingly different staining pattern. In
these cells large granules were observed (Figure 5F–H). In
the majority of cells ( 70%) the nucleus was not or only
faintly stained as exempliﬁed in Figure 5F and G. In other
cells few granules in the nucleus and an additional diffuse
granular cytoplasmic staining were observed (Figure 5H).
Figure 5. Different subcellular localization of two major ZBP1 splice variants. HeLa cells transiently transfected with ZBP1 were fixed and stained with
polyclonal anti-ZBP1 antibodies and with secondary RPE-conjugated anti-rabbit-Ig antibodies. The left pictures show red fluorescence (RPE) after identical
exposure time. The middle panels show nuclear stain using Hoechst33342. Right pictures show merges. In (A) no competitor was present, while in (B)1 0mg/ml
of recombinant ZabZBP1 was added. Anti-ZBP1 antibodies were used to stain for ZBP1 (left panels) in HeLa cells transfected with either full length ZBP1 (C–E)
or the splice variant ZBP1DZa (F–H). Cells representative of three independent experiments are shown.
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Figure 4. Binding of Z-DNA by ZBP1 Za proteins in electrophoretic mobility shift assays. EMSA were performed using
32P-labeled double-stranded (dC–dG)20
as probe in the presence of 20000-fold access of sheared salmon sperm DNA as unspecific competitor. (A) Molar concentration was adjusted for the number of
Za domains the protein comprises. Za and Zb was assayed in twice as high molar concentration as Zab. Migration of the free probe is shown in lane 1 and 13.
Zab (lane 2: 12.5 nM; lane 3: 25 nM; lane 4: 50 nM), Za (lane 5: 25 nM; lane 6: 50 nM; lane 7: 100 nM), and Zb (lane 5: 25 nM; lane 6: 50 nM; lane 7: 100 nM)
were assayed at indicated concentrations. Reaction mixes shown in lanes 11–13 were prepared at the same time and were run on a separate TBE Gel. Za and Zb
were mixed together at two concentrations (lane 11: 25 nM of each protein and lane 12: 50 nM of each protein) to see if there is a cooperative effect if both
domains are present in different molecules. Sometimes a minor, slower migrating band was observed (asterisk) for the probe, probably due to a different
secondary structure of the probe. (B)Z abADAR1 (lane 2) and ZabZBP1 (lane 3) form complexes with the radiolabeled probe whereas the indicated ZabZBP1
mutants at equimolar concentration do not (lanes 4–8). Migration of the free probe is shown in lane 1.
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Y50 in ZaZBP1 dramatically affects the subcellular
localization of ZBP1
To further analyze the subcellular localization of ZBP1 in
living unﬁxed cells, we cloned the two major splice variants
at the N-terminus of GFP in order to generate ZBP1-GFP
fusion proteins. The full length ZBP1-GFP fusion protein
showed a ﬁnely punctate cytoplasmic staining pattern
(Figure 6A), while ZBP1DZa-GFP was found in large,
mostly cytoplasmic granules (Figure 6B). This conﬁrms the
results obtained for untagged ZBP1 isoforms detected with
antibodies in ﬁxed cells. Additionally, mutations that substi-
tute amino acids important for Z-DNA binding or delete lar-
ger parts of the protein were tested in this assay. Asparagine
Figure 6. Correlation of subcellular localization of ZBP1 with the capability of the first Za domain to bind the Z-conformation. HeLa cells were transiently
transfected with the indicated ZBP1-EGFP expression plasmids for 8–12 h. Subcellular localization was analyzed by fluorescence microscopy (left panels).
Nuclei were stained with Hoechst33342 (middle panel). In (A) and (B) localization of the naturally occurring full length ZBP1 and ZBP1DZa, respectively,
tagged with GFP is shown. Localization is shown for GFP-tagged full length ZBP1 with the indicated single (C and D), double (E and F) or quadruple (G) amino
acid substitutions at residues important for Z-DNA binding. (H and I) show the localization of full length ZBP1 and ZBP1DZa proteins, respectively, after the
precise deletion of exon 4, which encodes the entire second Za domain. The localization of fusion proteins after deletion of the complete C-terminus (exons
6–10) is shown for ZBP1 (J) and ZBP1DZa (K). (L) shows the distribution of GFP alone within the cell. Two hours after transfection with full length ZBP1-GFP
(M) and ZBP1DZa-GFP (N) constructs, cells were treated with Leptomycin B, an inhibitor of nuclear export, for 8 h prior to microscopy. Cells representative of
at least three independent experiments are shown. (O) Western blot analysis shows that ZBP1-GFP fusion proteins were intact and not significantly degraded
10 h after transfection. Total cell lysates of transfected cells were subjected to SDS–PAGE and recombinant proteins were detected with an antibody directed
against GFP. In lane 1 lysate of mock-transfected cells is shown as control. Lane 2 shows lysate of GFP transfected cells. The letters written in parenthesis for
lanes 3–9 refer to the different fusion proteins that are shown in this figure as fluorescence pictures (A–K).
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observed in the co-crystal structure of mouse ZBP1 in com-
plex with Z-DNA (11). Mutation of either of these residues
led to a dramatically changed subcellular localization, from
a ﬁnely punctate distribution as seen in wild type ZBP1 to
large granules. In this respect the N46D (Figure 6C) substitu-
tion had a stronger effect than the Y50A (Figure 6D) substi-
tution. Mutation of both residues resulted in the formation of
large cytoplasmic granules (Figure 6E) that were indistin-
guishable to those formed by ZBP1DZa (Figure 6B). Muta-
tion of the corresponding residues in Zb (N141D/Y145A)
had no such effect. This mutant displayed a ﬁnely punctate
cytoplasmic ﬂuorescence pattern similar to that observed
for wild type ZBP1 and additionally showed nuclear accumu-
lation (Figure 6F). Substitution of all four residues, in both
Za and Zb, resulted in a comparable pattern to that observed
with ZBP1DZa (Figure 6G). Precise deletion of exon 4,
which encodes the complete Zb domain, resulted in a compa-
rable ﬂuorescence pattern to that observed for the N141D/
Y145A mutant. This deletion led to a ﬁnely punctate cyto-
plasmic ﬂuorescence pattern with some nuclear accumulation
(Figure 6H). When exon 4 was deleted from the ZBP1DZa
splice variant, large cytoplasmic granules were observed
(Figure 6I). Deletion of the C-terminal part from wild type
ZBP1 (Figure 6J) and ZBP1DZa (Figure 6K) resulted in a
homogenous distribution within the cell, which was compara-
ble to that of GFP alone (Figure 6L). No granularity or punct-
ate staining was observed. Western blot analysis of whole cell
lysates of transfected cells showed no signiﬁcant level of
degradation with an antibody against GFP (Figure 6O).
Because weak nuclear staining was observed in some cells
transfected with wild type ZBP1, we tested whether nuclear
export might play a role in directing the subcellular location
of ZBP1. To this end we treated HeLa cells 2 h after transfec-
tion with LMB, an inhibitor of nuclear export. An accumula-
tion of ﬂuorescence in the nucleus was observed for full
length ZBP1 (Figure 6M), which was comparable to that
observed with ZBP1DZb (Figure 6H). ZBP1DZa-GFP trans-
fectants treated with LMB showed cytoplasmatic granules
(Figure 6N) comparable to untreated transfectants
(Figure 6B). Additionally, weak nuclear accumulation was
observed (Figure 6N).
Association of ZBP1-containing cytosolic granules with
stress granules and processing bodies
The observed granules, especially those formed by ZBP1DZb,
are reminiscent of SGs. SGs are cytoplasmatic foci that are
assembled during environmental stress and are thought to
modify mRNA turnover and mRNA accessibility to the trans-
lational machinery (25,35). To determine whether ZBP1
might be a component of SGs, we generated fusion proteins
of full length ZBP1 and ZBP1DZa with mRFP and performed
co-transfection with GFP-tagged G3BP and TIA1, two
markers for SGs whose overexpression has been described
to induce the formation of SGs (25,27). Fluorescence pattern
of RFP-tagged ZBP1 was comparable to that of untagged
and GFP-tagged proteins, showing a ﬁnely punctate pattern
for full length ZBP1-RFP (Figure 7A) and large granules for
ZBP1DZa-RFP (Figure 7B and C). The ZBP1DZa granules
did not co-localize with granules marked by G3BP-GFP and
TIA1-GFP (Figure 7B and C). However some of the
ZBP1DZa granules appear to be closely associated with
G3BP-GFP and TIA1-GFP marked granules and even display
overlapping at contact areas. Granules marked by G3BP-GFP
are surrounded by full length ZBP1-RFP, which appears to be
concentrated around G3BP-marked granules (Figure 5A).
Another form of granules important for RNA turnover are
PBs, which can interact with SGs (35). Co-transfection of
RFP-tagged PB marker DCP1a with GFP-tagged ZBP1,
revealed an association with some DCP1a granules with
full length ZBP1 (Figure 7D) or with the large granules
formed by ZBP1DZa (Figure 7E).
We investigated the dynamics of the interactions between
ZBP1DZa granules and SGs or PBs over time taking photos
of individual cells every 30 s over a 15 min time period.
Some SGs as marked by TIA1-GFP (Figure 7F and
Video 1) and G3BP-GFP (Video 2) were tethered to
ZBP1DZa granules over the complete observation interval
(e.g. Figure 7F, yellow arrow), while other interactions
between these two granules appeared to be more intermittent
or temporary. The white arrow in Figure 7F marks a single
ZBP1DZa granule that was unbound at the beginning of
the observation period (Figure 7F, 0–3 min), later attached
to a TIA1-marked SG (Figure 7F, 6–9 min) and subsequently
split into two granules (Figure 7F, 12–15 min). In addition to
ﬁssion ZBP1DZa granules also displayed fusion of two or
more granules into a single larger granule (as observed in
Figure 7G middle right). Similarly to SGs, some DCP1a-
marked PBs stayed attached to ZBP1 granules over the
observed interval (Figure 7G, yellow arrow), while others
only temporarily interacted (Videos 3 and 4). The white
arrow in Figure 7G marks a PB that was unbound at the
beginning of the observation period, attached to a ZBP1DZa
granule after 2 min and stayed tethered to it until the end of
the observation interval. Generally, PBs appeared to be more
motile than SGs or ZBP1DZa granules, which showed a com-
parable degree of motility.
Stress-induced accumulation of full length ZBP1 into
stress granules and disassembly of ZBP1DZa granules
We investigated whether the localization of the two major
ZBP1 isoforms can be inﬂuenced by stimuli that modify the
assembly of SGs. To this end we co-transfected HeLa cells
with G3BP-GFP and either ZBP1-RFP or ZBP1DZa-RFP
and treated cells with arsenite for 1 h or subjected them to
heat shock for 30 min, two stimuli that promote SG assembly,
or treated cells with emetine, a drug that blocks the disas-
sembly of polysomes and leads to the disintegration of SGs
(25,36). Treatment of cells with emetine resulted in the disas-
sembly of SGs marked by G3BP (Figure 8B and F) as well as
a relocation of ZBP1DZa from granules to the cytoplasm
(Figure 8F). It had no effect on the localization of the full
length ZBP1. Treatment with arsenite (Figure 8C) or expo-
sure to heat shock (Figue 8D) lead to the relocation of full
length ZBP1 into granules which co-localized with the SG
marker G3BP. Heat shock was more effective in relocating
ZBP1 into the SGs than arsenite treatment. Exposure to
arsenite (Figure 8G) or heat shock (Figure 8H) had an oppos-
ing effect on ZBP1DZa, leading to the disassembly of gran-
ules, while G3BP granules were not effected. Comparable
Nucleic Acids Research, 2006, Vol. 34, No. 18 5015results were obtained when cells were co-transfected with
TIA1-GFP and when only ZBP1 was transfected (data
not shown). The granules formed by full length ZBP1-GFP
after heat shock and aresenite treatment did not co-localize
with Dcp1a-RFP (data not shown).
Online supplemental material
Video 1 shows the dynamic interaction of ZBP1DZa granules
(red) with TIA1 granules (green) in transiently transfected
HeLa cells. Video 2 shows the interaction of ZBP1DZa
granules (red) with G3BP granules (green). Videos 3 and
4 show the dynamic interaction of ZBP1DZa-GFP granules
(green) and DCP1a-RFP granules (red). Photos were taken
every 30 s over a 15 min time period and time lapse anima-
tions were made with 4 pictures per s.
DISCUSSION
The results presented in this paper provide insights into the
function of the two Z-DNA binding domains and different
isoforms of human ZBP1 and demonstrate association and
interaction of ZBP1 isoforms with SGs.
All proteins that can speciﬁcally bind to left-handed
Z-DNA and Z-RNA known to date contain Za domains
(15). Although the structure of all crystallized Za domains
is remarkably similar, not all of them can actually bind the
Z-form by their own (10–12,34). Using CD spectroscopy
we have shown that ZaZBP1 (encoded by exon 2) and
ZbZBP1 (encoded by exon 4) can bind to left-handed
Z-DNA independently of each other, resulting in comparable
CD spectra of DNA. This conﬁrms a recent report where both
domains, when tested independently, converted DNA from
the B- to the Z-form (37). In addition to this ﬁnding this
report shows that when both Za domains are tethered to
one another, as in the full length protein, the capacity to con-
vert DNA from the B-form to the Z-form is greatly enhanced.
Consistently, the results of EMSA experiments show that
formation of DNA–protein complexes is greatly augmented
when Zab is present in one protein molecule as compared
to the situation when Za or Zb were tested separately or
when Za or Zb are mixed together.
Figure 7. Association and dynamics of interaction of ZBP1 granules with SGs and PBs. HeLa cells were co-transfected with full length ZBP1-RFP (A),
ZBP1DZa-RFP (B and C), full length ZBP1-GFP (D) and ZBP1DZa-GFP (E) plus SG markers G3BP-GFP (A and B), TIA1-GFP (C) or PB marker DCP1a-RFP
(D and E). For each photo the indicated sections are shown in better resolution below for green, red and merged fluorescence. The dynamics of interaction
between ZBP1 granules with SGs and PBs are shown for co-transfections with ZBP1DZa-RFP and TIA1-GFP (F and Video 1), ZBP1DZa-RFP and G3BP-GFP
(Video 2) or ZBP1DZa-GFP and DCP1a-RFP (G and Videos 3 and 4). Cells were observed over a period of 15 min with pictures taken every 30 s. Pictures taken
at 3 min intervals are shown in F and G. White arrows indicate ZBP1 granules that were unbound at the beginning of the observation period and later attached to
SGs (F) or PBs (G). Yellow arrows indicate ZBP1 granules that stayed attached to SGs (F) or PBs (G) over the complete observation period. Cells representative
of at least three independent experiments are shown.
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ent levels of mobility. The larger protein Zab (19 kDa)
forms complexes which migrate faster and thus appear to
be smaller than the complexes formed by the single Za
(9.5 kDa) or Zb (10.9 kDa) domains. This might be caused
by the binding of more protein molecules to the probe if
the protein is smaller, leading to the formation of larger
complexes.
The importance of two intact Za domains in one molecule
for Z-DNA binding is further supported by the results of
our mutagenesis experiments. Mutation of conserved amino
acids that contact Z-DNA as seen in the crystal structures
(N46, Y50, N141, Y145) resulted in a dramatically reduced
capacity to bind Z-DNA. Interestingly, Z-DNA binding of
Zab was strongly affected even when these amino acids
were substituted in only one of the Za domains.
The results of our in vitro Z-DNA binding experiments led
us to hypothesize that the two major isoforms of ZBP1 might
show different subcellular distribution. Indeed, following
transfection into HeLa cells, full length ZBP1 and ZBP1DZa
displayed strikingly different subcellular localizations.
While both isoforms displayed a predominant cytoplasmic
Figure 8. Relocation of full length ZBP1 and ZBP1DZa upon arsenite treatment and heat shock. HeLa cells were co-transfected with G3BP-GFP and full
ZBP1-RFP (A–D) or ZBP1DZa (E–H). After 7 h cells were incubated with 100 mg/ml emetine (B and F) or 500 mM arsenite for 1 h or exposed to heat shock at
44 C for 30 min (D and H). Upper panels show RFP fluorescence, middle panels GFP fluorescence and lower panels the merged views. Cells representative of at
least three independent experiments are shown. Supplementary Data.
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ate distribution, whereas ZBP1DZa localized in large gran-
ules. Importantly, the ﬁnely punctate distribution of ZBP1
correlates with its ability to bind the Z-conformation, since
single or double mutations of the Z-DNA contacting residues
in ZaZBP1 (N46D and Y50A) resulted in a distribution similar
to that of ZBP1DZa.
No such effect was observed with analogous mutations of
ZbZBP1, even if the complete domain was deleted. It appears
that ZaZBP1 exerts a dominant effect over ZbZBP1 with
respect to the localization. This result could not be expected
from the in vitro experiments, in which both Za and Zb
appeared to bind Z-DNA with comparable efﬁciency. How-
ever, deletion of Zb or mutation of its presumptive Z-DNA
contacting residues N141 and Y145 resulted in accumulation
of protein in the nucleus, indicating that a functional ZbZBP1
is involved in nuclear export of ZBP1. Importance of nuclear
export is further supported by nuclear accumulation of full
length ZBP1 after treatment with LMB, an inhibitor of
nuclear export.
C-terminal ZBP1 deletion mutants (lacking exons 6–10),
irrespective of the presence or absence of ZaZBP1, showed
a homogenous distribution within the cell, including the
nucleus, similar to that of GFP. The C-terminal truncated
ZBP1E1-5 and ZBP1E1-5DZa fused to GFP have a predicted
molecular mass of 52 and 44 kDa, respectively. They appear
to be too large to pass the nuclear pore by diffusion, where
the cut-off is believed to be between 20 and 40 kDa (38).
This indicates that there might be another nuclear export
signal apart from ZbZBP1 in the C-terminus of ZBP1. Western
blot analysis showed that all ZBP1-EGFP fusion proteins
were intact, demonstrating that the different observed
ﬂuorescence patterns were not a consequence of protein
degradation.
The resemblance of the ZBP1-harboring granules with
SGs and PBs led us to investigate whether ZBP1 might be
actually a component of these. SGs and PBs are RNA gran-
ules which play important roles in mRNA turnover. Transla-
tionally silenced mRNA can be packed into these granules
and either be degraded or stored and later exported. It is
believed that SGs function as triage centers that sort, remodel
and export mRNA either for subsequent decay (e.g. export to
PBs) or for reinitiation of translation (25,28,35).
It has been shown that SG formation can be promoted by
the overexpression of SG proteins G3BP and TIA1 (27,39).
Co-transfection experiments showed that G3BP- and
TIA1-marked granules are distinct from the ZBP1DZa
marked granules. However, a close spatial association with
overlapping contact areas between SGs and ZBP1DZa gran-
ules was often observed. A similar association was seen with
ZBP1DZa granules and some PBs marked by the decapping
enzyme DCP1a. Time lapse microscopy showed that these
interactions are dynamic. Some ZBP1DZa granules were
tethered to SGs or PBs over the complete observation period,
while some only associated for a limited time. Upon contact
with one another, SGs and ZBP1DZa granules often appeared
to deform and reshape. They share some characteristic
features, which include interaction with PBs, fusion and
ﬁssion (25).
The granules induced by the overexpression of SG protein
G3BP are thought to be genuine SGs because they contain
typical SG proteins such as PABP1, eIF4G, TIA1 and
TIA1/R (27,39). The ﬁnding that full length ZBP1 can
actually localize into G3BP- and TIA1-marked SGs only
after cells have been subjected to environmental stress, i.e.
heat shock and arsenite exposure, indicates that G3BP- and
TIA1-containing granules in unstressed transfected cells
contain ‘stress-independent’ components that are assembled
following the overexpression of these proteins. Other proteins
such as ZBP1 enter these ‘pre-formed’ granules only after
cells have been subjected to environmental stress (stress-
dependent).
Inhibitors of translational elongation, such as emetine and
cyclophosphamide, impede the disassembly of polysomes
and dissolve SGs and PBs. Since mRNA shuttle between
SGs and polysomes, this leads to a shift in the equilibrium
of mRNAs towards the polysome fraction, resulting in the
disintegration of SGs, because mRNA are integral compo-
nents of SGs and PBs (24,36,40). Interestingly, treatment of
cells with emetine led to the disassembly of both SGs and
ZBP1DZa granules, indicating that mRNA may also be an
integral component of the latter. It will be interesting to deter-
mine other components of ZBP1DZa granules and analyze
whether proteins and RNA, which are found in SGs and
PBs, are also present in ZBP1DZa granules. Remarkably,
exposure of cells to arsenite and heat shock dissolved the
ZBP1DZa granules. The dynamic nature of ZBP1DZa gran-
ules indicates that these granules do not represent mere aggre-
gates of misfolded proteins. A similar phenomenon has been
observed for the AU-rich element binding protein triste-
traprolin (TTP). TTP was recruited to SGs after FCCP-
induced energy starvation but excluded form SGs in arsenite
treated cells. Overexpression of TTP resulted in the formation
of SGs, which disassembled after arsenite treatment (41). The
exclusion of TTP from SGs was shown to be regulated by the
phosphorylation of 14-3-3 proteins via the p38-MAPK/MK2
pathway (41).
Due to the predominant cytoplasmatic localization of
ZBP1 it appears that cellular RNA might be a more likely
target than cellular DNA. However, as potential Z-DNA
forming sequences are found in the genomes of some viruses,
e.g. simian virus 40, adenoviruses (6), herpes simplex virus
and molluscum contagiosum virus (S. Rothenburg, unpub-
lished), it seems also possible that a major target for ZBP1
is viral Z-DNA or Z-RNA. Indeed ZBP1 is strongly induced
after immunostimulation by interferons (18) and its exp-
ression is tightly associated with inhibition of Hepatitis B
virus replication in a mouse model (42). ZBP1 was further
reported to be strongly induced after serum starvation (43).
A recent report demonstrated a strong induction of ZBP1
mRNA in mouse embryonic ﬁbroblasts by transfected
double-stranded DNA that was dependent on the protein
kinase TBK1, a key regulator of the interferon response
(44). This indicates that ZBP1 participates in antiviral
responses triggered by viral DNA independent of other sen-
sors for nucleic acid like Toll-like receptors and the helicase
RIG-1 (44).
Additionally or alternatively, the natural targets for ZBP1,
ADAR1, PKZ and E3L Za domains might be structured RNA
that resemble the Z-conformation or slightly differ from
it. The latter view is supported by the ﬁnding that ZaZBP1
is more important in determining the subcellular localization
5018 Nucleic Acids Research, 2006, Vol. 34, No. 18than ZbZBP1 despite comparable behavior of both domains
in in vitro assays for the induction and binding of Z-DNA.
This implies that ZaZBP1 might recognize the physiological
target(s) better than ZbZBP1.
In this study we demonstrate that ZBP1 isoforms show
different subcellular localizations, controlled by its ﬁrst
Z-DNA binding domain. While full length ZBP1 shows a
cytosolic ﬁnely punctate distribution, the ZBP1DZa isoform
as well as the mutants N46D and Y50A localize in large
granules. ZBP1DZa granules are distinct from but interact
dynamically with granules formed by SG and PB proteins.
Furthermore, we identiﬁed full length ZBP1 as a previously
unknown component of SGs induced by heat shock and
arsenite treatment. The inducible redistribution of ZBP1
into SGs on one hand, and the association and dynamic inter-
action of ZBP1DZa with granules containing G3BP, TIA1
and DCP1a on the other hand, support the notion that ZBP1
isoforms play distinct roles in the regulation of mRNA meta-
bolism and/or in the cellular defense system against viruses.
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